Alexey Margolin

Alexey Margolin is a highly experienced pharmaceutical executive with a significant track record in leadership and innovation within the industry. Currently serving as the Chairman of the Board at Anagram Therapeutics, Inc., Alexey has held prominent roles such as Director and Co-Founder and CEO at Alcresta Therapeutics since September 2011. Previous leadership positions include Chairman of the Board at Synspira Therapeutics, Inc. from October 2020 to March 2023, and Chairman of the Board at Allena Pharmaceuticals, where Alexey also served as Co-Founder and CEO from September 2011 to January 2019. Additionally, Alexey was Co-Founder and CEO of Alnara Pharmaceuticals and held the role of Chief Scientific Officer at Altus Pharmaceuticals from 1993 to 2007. Alexey Margolin earned a Doctor of Philosophy in Chemistry from Lomonosov Moscow State University.